Executive summary

This project is all about the study of vaccines prescribed by doctors for Cervical cancer. It is about the study of cervical cancer among women in India with the help of Quantitative and Qualitative study. Various methodologies have been used for the study of this project. Almost all the steps have been taken into consideration at the time of study of this project. The report starts with the company profile of TNS India Pvt. Ltd. Which focuses on different operational aspect of the company. Followed by the company profile the report takes you to different stages of marketing research. The sample size for this project was 40 and the location which we have chosen for this study was Bangalore. We have taken interviews of doctors who are specialized in the respective areas. The segmentation for this project at the time of taking interview was a) Pediatrician b) Gynecologist c) Dermatologist d) General Physician. After collecting all the data the analysis of this project has been analyzed through different tools like SPSS software and Microsoft excel. At the time of coding all the coding guidelines has been taken in to account. The analysis has been done as per the requirement of the company and various measures has been taken in to account for the accurate measure of the analysis.

Index

Sr .No. 1 About the company
1.1 History 1.2What TNS does 1.3 TNS Global Facts and Figures

Title

Page No.

1

1.4 Market Research in India 1.5 TNS Vision

2 3

SWOT Analysis Cervical Cancer
3.1Sign and Symptoms 3.2 Causes 3.3Preventive vaccination(HPV Vaccine) 3.4 Gardasil 3.5 Cervarix

6 7
8 9 10 11 12

4

Market Research
4.1Market Research Process 4.2 Flow Chart 4.3 Explanation of Research Processes 13 14-15 15-19

5

PLIN ( Project launch information Note )

20-22

6

Field Division 6.1 Briefing 6.2 Tele calling 6.3Quality Assurance 23 24 25

7

Punching and Coding 7.1Coding Guidelines 7.2 Coding-DP Interaction

26

26 27

About the Company
TNS( Taylor Nelson Sofres) Taylor Nelson Sofres is a leading market research and market information group. Formerly listed on the London Stock Exchange and a constituent of the FTSE 250 Index, the firm was acquired by WPP Group in October 2008 for 1.6 billion pounds. TNS Global is one of the world's leading market research groups. It provides Industry Sector Insight, and Innovative Market Research Solutions, to many of the world’s leading companies. TNS is providing market research services to almost all the sectors like Automotive; Brand and Finance; FMCG (CPG); Interactive research Communications; Custom Research; (inc. Access Panels); Innovation and Product Development; Opinion Polling; Political and Social; Retail & Shopper; Stakeholder Management; Technology. TNS is having so many clients including national and international clients all over the world like P&G, Toyota, Microsoft, Renault, Unilever, Nissan, HSBC, VW, Samsung, Barclays, Honda, Philips, Ranbaxy, etc.

History The history of TNS as a market research company began in 1946 with the establishment of National Family Opinion (NFO) in the United States. Since then, various mergers and acquisitions involving large companies from the US, Europe and Asia Pacific eventually became the Taylor Nelson Sofres group. The 1960s saw the establishment of the six main companies that today form part of TNS. Starting with NFO in the 1940s, Intersearch in the US in 1960; then AGB in the UK in 1962; Sofres in France in 1963; Frank Small Associates (FSA) in Australia in 1964; Taylor Nelson in

the UK in 1965. Over the 60s, 70s, 80s and 90s, these companies grew significantly as individual businesses.

What TNS does – Market Research TNS Global are one of the world's leading market research groups. It provide Industry Sector Insight, and Innovative Market Research Solutions, to many of the world’s leading companies. At a Glance World leading market research services across ... Automotive; Brand and Communications; Custom Research; Finance; FMCG (CPG); Interactive research (inc. Access Panels); Innovation and Product Development; Opinion Polling; Political and Social; Retail & Shopper; Stakeholder Management; Technology What TNS deliver... Truly Global Industry Sector capabilities, Market Research Expertise across the entire product lifecycle, Global footprint covering 70 countries, Focus on Market Insight. Operations TNS has chosen to specialise in eight market sectors:
• • • • • •

Automotive Consumer Finance Healthcare Media Political and social

• •

Technology Worldpanel

TNS separates its worldwide operations in over eighty countries into four main divisions: North America, Europe, Asia Pacific and emerging markets.

TNS Global Facts and figures TNS Global is the leading market research agency in most European countries. In the US, TNS Global is the largest custom market research provider. In Asia, TNS Global has the strongest custom market research network. TNS Global Size and scope
 

TNS is the World's largest custom market research company. TNS Global has offices in more than 75 countries across Africa, Americas, Asia Pacific, Europe and the Middle East.

 

Member of The Kantar Group, the information and consultancy division of WPP. View our comprehensive list of A-to-Z Insight services

Some of the Facts…
   

The world’s largest custom research business. Global leader in customer stakeholder management research. Biggest provider of online market information in the world. Global leader in opinion polling, political and social research.

Specialist market sectors

• • • • •

Automotive Consumer (FMCG) Finance Political and Social Technology

Areas of expertise
• •

Custom Research Brand and Communications (inc. Brand, Segmentation & Positioning, Advertising, Commitment) Stakeholder Management New Product Development Retail & Shopper Opinion Polling Interactive research (inc. Access Panels)

• • • • •

The combination of TNS and RI provides us with a unique set of assets and capabilities:
• •

Market leader in the majority of countries, worldwide The only custom research company organised around our client’s industry sectors and therefore “speaking our clients’ language” The largest professional resource in the world Deploying the most efficient suite of business solutions

• •

Market Research In India

TNS India Pvt., Ltd. provides market research services. The company offers various customized quantitative and qualitative research techniques and solutions, including proprietary market feedback models in the areas of brand health, tracking, segmentation, and advertising effectiveness. It serves fast moving consumer goods, technology, finance, media, healthcare, automotive, and political and social sectors. The company is based in New Delhi, India. TNS India Pvt., Ltd. operates as a subsidiary of Taylor Nelson Sofres plc.

TNS India is the country’s leading and fastest growing customised market research group, offering clients a wide range of market research insights and solutions. India’s leading market research company TNS India offers a range of comprehensive market research services catering for local and international clients that want to get a deep understanding of both urban and rural India life.

Market Research Expertise
TNS India offers clients a wide range of customised quantitative and qualitative market research techniques and solutions, including proprietary market feedback models covering areas of brand health, tracking, segmentation and advertising effectiveness. Our strength lies in our approach to service – we were the first and currently only Indian market research organisation to receive ISO certification for our operations. Industry Sector focus It works in and across most of the major business sectors: FMCG; Technology; Finance; Media; Healthcare; Automotive; Political & Social.

TNS vision
Looking forward, the strategic goal of TNS is:

“To be the most successful and admired company in the market research industry;

known for being consistent and reliable but also famous for challenging our clients and innovating around their evolving business needs.”

SWOT Analysis
Strength
• • Approach to service Over 60 years of market research heritage • • Presence over more than 75 countries The most successful and admired company industry • • Track record-successful assignments The world’s leading provider of in the market research • • • • • •

Weakness
• • Lots of paperwork The company is not able to build a brand image Very complex procedure Field word is very hectic No proper approach of target clients Less investment n advertisements Data can be manipulated No control on lower level employees

customized research services

theg p
Opportunity
• • • To create monopoly in the market To be the reliable research agency In the time of economic slowdown it has chance to get more research work foe the companies • To create more career option • • •

Threat
• Competitor intention(Other small agency looking to invade the marketplace) Drawbacks of Market Research Sustaining internal capabilities New entrants

Cervical Cancer:
Cancer that forms in tissues of the cervix (the organ connecting the uterus and vagina). It is usually a slow-growing cancer that may not have symptoms but can be found with regular Pap tests (a procedure in which cells are scraped from the cervix and looked at under a microscope). It is malignant cancer of the cervix uteri or cervical area. It may present with vaginal bleeding but symptoms may be absent until the cancer is in its advanced stages. Treatment consists of surgery (including local excision) in early stages and chemotherapy and radiotherapy in advanced stages of the disease. Pap smear screening can identify potentially precancerous changes. Treatment of high grade changes can prevent the development of cancer. In developed countries, the widespread use of cervical screening programs has reduced the incidence of invasive cervical cancer by 50% or more. Human Papillomavirus (HPV) infection is a necessary factor in the development of nearly all cases of cervical cancer. HPV vaccine effective against the two strains of HPV that cause the most cervical cancer has been licensed in the U.S. and the EU. These two HPV strains together are currently responsible for approximately 70% of all cervical cancers. Since the vaccine only covers some high-risk types, women should seek regular Pap smear screening, even after vaccination.

Signs and symptoms
The early stages of cervical cancer may be completely asymptomatic Vaginal bleeding, contact bleeding or (rarely) a vaginal mass may indicate the presence of malignancy. Also, moderate pain during sexual intercourse and vaginal discharge are symptoms of cervical cancer. In advanced disease, metastases may be present in the abdomen, lungs or elsewhere. Symptoms of advanced cervical cancer may include: loss of appetite, weight loss, fatigue, pelvic pain, back pain, leg pain, single swollen leg, heavy bleeding from the vagina, leaking of urine or faeces from the vagina, and bone fractures.

Causes
Human papillomavirus infection The most important risk factor in the development of cervical cancer is infection with a high-risk strain of human papillomavirus. The virus cancer link works by triggering alterations in the cells of the cervix, which can lead to the development of cervical intraepithelial neoplasia, which can lead to cancer. Women who have many sexual partners (or who have sex with men or women who had many other partners) have a greater risk. More than 150 types of HPV are acknowledged to exist (some sources indicate more than 200 subtypes). Types 16 and 18 are generally acknowledged to cause about 70% of cervical cancer cases. Together with type 31, they are the prime risk factors for cervical cancer. Genital warts are caused by various strains of HPV which are usually not related to cervical cancer. The medically accepted paradigm, officially endorsed by the American Cancer Society and other organizations, is that a patient must have been infected with HPV to develop cervical cancer, and is hence viewed as a sexually transmitted disease, but most women infected with high risk HPV will not develop cervical cancer. Use of condoms reduces, but does not always prevent transmission. Likewise, HPV can be transmitted by skin-to-skin-contact with infected areas. In males, HPV is thought to grow preferentially in the epithelium of the glans penis, and cleaning of this area may be preventative.

Staging

Cervical cancer is staged by the International Federation of Gynecology and Obstetrics (FIGO) staging system, which is based on clinical examination, rather than surgical findings. It allows only the following diagnostic tests to be used in determining the stage: palpation, inspection, colposcopy, endocervical curettage, hysteroscopy, cystoscopy, proctoscopy, intravenous urography, and X-ray examination of the lungs and skeleton, and cervical conization. The TNM staging system for cervical cancer is analogous to the FIGO stage.

Stage 0 - full-thickness involvement of the epithelium without invasion into the stroma (carcinoma in situ) Stage I - limited to the cervix
o

IA - diagnosed only by microscopy; no visible lesions

IA1 - stromal invasion less than 3 mm in depth and 7 mm or less in horizontal spread IA2 - stromal invasion between 3 and 5 mm with horizontal spread of 7 mm or less

o

IB - visible lesion or a microscopic lesion with more than 5 mm of depth or horizontal spread of more than 7 mm
 

IB1 - visible lesion 4 cm or less in greatest dimension IB2 - visible lesion more than 4 cm

Stage II - invades beyond cervix
o o

IIA - without parametrial invasion, but involve upper 2/3 of vagina IIB - with parametrial invasion IIIA - involves lower third of vagina IIIB - extends to pelvic wall and/or causes hydronephrosis or non-functioning kidney

Stage III - extends to pelvic wall or lower third of the vagina
o o

• •

IVA - invades mucosa of bladder or rectum and/or extends beyond true pelvis IVB - distant metastasis

Prevention

Awareness According to the US National Cancer Institute's 2005 Health Information National Trends survey, only 40% of American women surveyed had heard of human papillomavirus (HPV) infection and only 20% had heard of its link to cervical cancer. In 2008 an estimated 3,870 women in the US will die of cervical cancer, and around 11,000 new cases are expected to be diagnosed.

Preventive Vaccination HPV vaccine
Merck & Co. has developed a vaccine against four strains of HPV (6,11,16,18), called Gardasil. It is now on the market after receiving approval from the US Food and Drug Administration on June 8, 2006. Gardasil has also been approved in the EU. GlaxoSmithKline has developed a vaccine called Cervarix which has been shown to be 100% effective in preventing HPV strains 16 and 18 and is effective for more than four years. Cervarix has been approved some places and is in approval process elsewhere. Neither Merck & Co. nor GlaxoSmithKline invented the vaccine. The vaccine's key developmental steps are claimed by the National Cancer Institute in the US, the University of Rochester in New York, Georgetown University in Washington, DC, Dartmouth College in Hanover, NH, and the Queensland University in Brisbane, Australia. Both Merck & Co. and GlaxoSmithKline have licensed patents from all of these parties. Together, HPV types 16 and 18 currently cause about 70% of cervical cancer cases. HPV types 6 and 11 cause about 90% of genital wart cases. HPV vaccines are targeted at girls and women of age 9 to 26 because the vaccine only works if given before infection occurs; therefore, public health workers are targeting girls before they

begin having sex. The use of the vaccine in men to prevent genital warts and interrupt transmission to women is initially considered only a secondary market. The high cost of this vaccine has been a cause for concern. Several countries have or are considering programs to fund HPV vaccination. HPV types can cause warts or some types of cancer, while others have no symptoms. Most people who become infected with HPV do not know they have it. About 30-40 HPV types are typically transmitted through sexual contact and infect the anogenital region. Some sexually transmitted HPV types may cause genital warts. Persistent infection with "high-risk HPV types—different from the ones that cause warts—may progress to precancerous lesions and invasive cancer. HPV infection is a cause of nearly all cases of cervical cancer.

Gardasil
Gardasil is manufactured by Merck & Co. It is a vaccine against certain types of human papillomavirus (HPV). It is designed to prevent infection with HPV types 16, 18, 6, and 11. HPV types 16 and 18 currently cause about 70% of cervical cancer cases, and also cause some vulvar, vaginal, penile and anal cancers. It is important to note, however, that the great majority of high-risk HPV infections go away on their own and do not cause cancer. HPV types 6 and 11 cause about 90% of genital warts cases. It is only effective in preventing HPV infections, not in treating those already infected by HPV, and so the vaccine must be given before HPV infection occurs in order to be effective. For this reason it is recommended to administer the vaccine before adolescence and the onset of sexual activity.

Gardasil can also be used to vaccinate males against HPV, though it has not yet been approved by the FDA to be marketed as such, providing protection against genital warts and some potentially precancerous lesions caused by some HPV types. An ongoing study of 4,065 males demonstrated the efficacy of Gardasil in males who did not have HPV infection prior to vaccination. The vaccination is expected to protect against penile cancer and anal cancer caused by included HPV types, and research in this area is still underway. In December 2008, Merck asked the FDA for permission to market the vaccine in the United States for males between ages 9 to 26. In the UK HPV vaccines are already licensed for males aged 9 to 15 and for females aged 9 to 26. Gardasil is in particular demand among gay men, who are at significantly increased risk for genital warts and anal cancer caused by HPV

Efficacy The National Cancer Institute says, "FDA-approved Gardasil prevented nearly 100 percent of the precancerous cervical cell changes caused by the types of HPV targeted by the vaccine for up to 4 years after vaccination." The vaccine is believed to be effective for longer, but for how long, and whether a booster shot will be needed is still being studied.

Cervarix
Cervarix is manufactured by GlaxoSmithKline. It is also a vaccine against certain types of the human papillomavirus (HPV). It is a preventative cervical cancer vaccine, not therapeutic. HPV immunity is type-specific, so a successful series of Cervarix shots will not block infection from cervical cancer-causing HPV strains other than HPV 16, 18, 31 and 45, so experts continue to recommend routine cervical Pap smears even for women who have been vaccinated.

It is designed to prevent infection from HPV types 16 and 18, which currently cause about 70% of cervical cancer cases. Type 16 is also associated with oropharyngeal squamous-cell carcinoma, a form of throat cancer. Additionally, some cross-reactive protection against virus strains 45 and 31 were shown in clinical trials. Cervarix is also formulated with AS04, a proprietary adjuvant that has been found to boost the immune system response for a longer period of time. Cervarix is used by the UK government for its national programme of vaccination for teenage girls. This caused some controversy since Cervarix was chosen over Gardasil apparently for cost reasons, even though Gardasil protects against HPV strains 6 and 11 in addition to 16 and 18. Cervarix has been used to vaccinate girls aged 12–13 and 17–18 against HPV as part of the UK Government’s cervical cancer vaccination campaign.

Market Research
Business firms’ use of marketing research has grown continuously over the past fifty years, since managers painfully learned the cost of market ignorance. Its use has extended now into political and other nonbusiness organization. The modern manager must have knowledge of its methods and how to use it profitably. Marketing research is the systematic gathering, recording, and analyzing of data about problems relating to the marketing of goods and services. The key word that distinguishes research from a gathering of observation is systematic.The systematic conduct of research requires particularly these two qualities:(a)orderliness, in which the measurements are accurate and the cross section is fair, and (b)impartially in analysis and interpretation.

All of research can be categorized into basic and applied. Basic research is that intended to expand the body of knowledge in a field or to provide knowledge for the use of others. Applied research is carried on for the solving of a particular problem or for guiding a specific decision, and usually its results are private.

The Marketing Research Processes
The marketing research process includes the systematic identification, collection, analysis and distribution of information for the purpose of knowledge development and decision making. The reasons and times at which one company or organization might consider performing marketing research varies, but the general purpose of gaining intelligence for decision making remains constant throughout. Customers occupy the central role in the marketing research process. As a company or organization, the overwhelming majority of research the researcher currently considering likely revolves around the customers:
• • • • • • •

Current customers Prospective customers Lost customers Members Community Employees (internal customers) Shareholders (internal customers)

Whether Researcher creating a new marketing research program or perhaps revising an existing marketing research program, there are some steps involved in it, each of those steps fits into one of the 11 major steps of the marketing research process. They are:

Flow chart of market research process
Establishing the Need for Marketing Research

Defining the Problem

Establishing Research Objectives

Determining Research Design

Identifying Information Types and Sources

Determining methods of Accessing Data Designing Data Collection Forms

Determining Sample Plan and Size

Collecting Data

Analyzing Data

Preparing and Presenting the Final Research Report

Step One:

Establishing the Need for Marketing Research

It is important to established the need of marketing research. In some situation Marketing Research is not needed when: • • • • The information is already available Decisions need to be made now We can’t afford research Costs outweigh the value of the research

Step Two: Defining the Problem
It is the most important step in the marketing research process is defining the problem. At this point, the problem will have been recognized by at least one level of management, and internal discussions will have taken place. Sometimes, further definition of the issue or problem is needed, and for that there are several tools a researcher can use.

Step Three: Establishing Research Objectives
What information is needed in order to solve the problem?

With a marketing problem or opportunity defined, the next step is to set objectives for the market research operations. The objective might be to explore the nature of a problem so the researcher may further define it. Or, perhaps it is to determine how many people will buy the product packaged in a certain way and offered at a certain price. The objective might even be to test possible cause and effect relationships.

Step Four: Determining Research Design
• •

Exploratory Research: collecting information in an unstructured and informal manner Descriptive Research: refers to a set of methods and procedures describing marketing variables

Causal Research (experiments): allows isolation of causes and effects

Step Five: Identifying Information Types and Sources
There are two types of research: primary research or original information gathered for a specific purpose and secondary research or information that already exists somewhere. Both types of research have a number of activities and methods of conducting associated with them. Secondary Data: information that has been collected for some other purpose other than the research at hand Primary Data: information that has been gathered specifically for the research objectives at hand

Step Six: Determining Methods of Accessing Data
Secondary Data: accessing data through sources such as the Internet and library Primary Data: collecting data through methods such as telephone, mail, and face-to-face (quantitative) and observation studies and focus groups (qualitative).

Step Seven: Designing Data Collection Forms
Regardless of the technique used to collect the data, the researcher must decide on how to the collect the data. This is particularly crucial for survey research that relies on questionnaires and/or response sheet to record data collected in a consistent manner. The design of the data collection form that is used to ask and record information in marketing research projects is critical to the success of the project. • • Questionnaires Observation Studies

Step Eight: Determining Sample Plan and Size
Sample plan: refers to the process used to select units from the population to be included in the sample. Sample size: refers to determining how many elements of the population should be included in the sample.

Step Nine: Collecting Data
Data collection is very important because, regardless of the data analysis methods used, data analysis cannot “fix” bad data. Non sampling errors may occur during data collection.

Step Ten: Analyzing Data

Data analysis: involves entering data into computer files, inspecting data for errors, and running tabulations and various statistical tests Data cleaning: process by which raw data are checked to verify that the data have been correctly inputted from the data collection form to the computer software program

Step Eleven: Preparing and Presenting the Final Research Report
The last step is one of the most important phases of marketing research. Its importance cannot be overstated because it is the report, or its presentation, that properly communicates the results to the client.

----------------------------------------------------------------------------------------------------

PLIN ( Project launch information Note )

HEALTHCARE PRACTICES TNS INDIA Rev No. Originating Branch PLIN approved by: SECTION 1: BACKGROUND Study objectives 00 Project Launch Information Note (PLIN) PROJECT TITLE Guardian Date: Job Dt: Dt: 810074 11/02/09

Mumbai

PLIN Raised by: Swati Shankar

 

The client has launched its HPV vaccine in India. The overall objective is to track the impact & effectiveness of various sales & marketing activities carried out for their HPV vaccine on continuous basis.

Category

Health Care

Study stages

The study type is Quantitative.

In this stage we interviewed only doctors. Field’s role was to identify the respondents and administer the questionnaire by ascertaining the eligibility of respondents.

Target group / respondent profile • Pediatricians (mostly)

• • •

General physicians (mainly ladies) Gynecologist (for warts) Dermatologists

SECTION 2: STUDY SPECIFICS

Study design The study was a quantitative exercise using purposive sampling; a structured questionnaire was used as the data collection instrument. In this study client was interested to know the perception of doctors as well as patients, brand positioning of their vaccines.

Sampling Plan for recruiters:

 Sampling technique opted for this project was convenience sampling  Depending on the productivity of the field please dispatch the completed questionnaire.
 The completed questionnaires must be sent to DP centre (to Bangalore).

 Closely monitor the initial days to identify and rectify issues. Revert if you face any problems in productivity.  Ensure proper administration of interview – no hurrying and strictly adhere to all instructions provided in the questionnaire and the accompanying field material.

We maintained questionnaires for unsuccessful contacts also. Also, kept track of the number of contacts required to achieve the quotas – this information was needed for reviewing

Centers for the Study: Bangalore Sampling plan for recruiters:

Quotas need to be maintained

Sampling for Tracking of Gardasil GARDASIL Bangalore Grand Total Zones GYN DER PAED GP S S 15 15 5 5 15 15 5 5 Total 40 40

Other Instructions/Info:

Material enclosed

 

Questionnaire Budget EWN(Time schedule)

Activity / milestone Dispatch of questionnaires Dispatch of other field material Field briefing / mock calls Fieldwork start Fieldwork completion First lot of questionnaire to be dispatched to DP Last lot of questionnaire to be dispatched to DP Latest date for receipt of complete lot of questionnaires by DP

Date(s)

Field Division
TNS India Ltd Bangalore is having separate Field division in Bangalore consist of many experienced field executives. Before starting field work for the data collectionpurpose, briefing of the project is being done on the phone where the Researcher explain all the key points of the Questionnaire to the Field manager. If the Field manager feels that there is something wrong in the Questionnaire or any modification needs to be done in the Questionnaire from the interview

point of view then he can suggest this to the researcher for doing necessary changes in the Questionnaire. Briefing: Briefing is a process in which a researcher explains to the Field officer / executive about the project details. He explains what all precautions he has to take at the time of the interview. Following things are important in Briefing. Objectives What initiated the requirement for research? Where did this come from:• Business • Sales & Marketing • Product Development What are the questions that the research should address? How will the results of the research be used? How important for the business is the output from this research? Who are the primary sponsors of the research? Target Audience What is the target audience/target market for the research? Are these customers or non-customers? Are there any limits on the target audience for the research e.g. Organisational definitions • Company size (turnover, no of employees) • Industry sector • Channel Participant/respondent definitions • Job title/role • Level of seniority • Degree of buying influence • Special expertise/qualifications Which geographic areas should the research cover?

Are these of equal importance or are some more important than others? Which areas are the most important? Approach Is the research to:a) measure and quantify attributes of the target audience or to b) provide and in-depth understanding of the target audience in areas such as opinions/perceptions, behaviour and response to ideas, concepts or product/service? c) None of these (please elaborate) If (a):• Are the measurements to be repeated over time so that trends can be identified? • Are the measurements to be compared to equivalent data for your competitors or other organizations? If (b):• What level of understanding are you seeking from the research? Scope What are the key subject areas to be covered by the research? Is the research testing any concepts or ideas? If so, what are they? Is the research testing any hypothesis or internal opinion/perspective? If so what is it? Deliverables What format are the findings from the research to be delivered:Hard copy Soft copy Summary report (Summary findings) Full Report (Detailed findings, conclusions and management summary) Full presentation Timescales & Budget When will you be able to give the go-ahead for the research? When are the results required by? Is budget currently approved and allocated to this project? If not where will the budget be sought from? If yes what is the budget available?

Tele calling – This is one of the source through which we can reach to the respondents. This is
the means of communication through which we can communicate to the respondents for fixing the interview. For this project we were provided database of several doctors of Bangalore. We made calls and fixed appointment with different specialist doctors and collected data for our project.

Quality Assurance –
TNS is having separate division of Quality assurance in which after the sample size gets collected. Quality assurance team cross check with the respondents that weather he/she has really given any interview or not. After verifying with that particular respondent that data were accepted. The data of each and every form goes into verification to avoid any misrepresentation of data. Quality Assurance teams cross checks all their doubts before approving the overall sample size and before sending the questionnaire to the punching department.

Punching / Coding– TNS Is having separate punching department and that is also divided in
to two groups 1. Adhoc study 2. Track study Adhoc Study – This is the division in which project is coming for the first time and coding is done here in this department Track study – This is the department in which repeated projects are done here and coding is done in this department.

CODING GUIDELINES

How to start a coding job ? 1. DA must send the PLIN / EWN / Sampling details to the coding department. 2. After receiving the project details, Coding supervisor should plan and allocate resource according to the size and complexity of the project. 3. If coding brief not provided, Coding supervisor can contact the concerned DA and request for the same to start work. 4. Coding supervisor should brief the coding team on a) Checklist for doing the questionnaire scrutiny b) Open end question / others-specify questions to be coded c) Predefined code frames if available d) Other instruction from DA on code frame preparation and maintenance.

Coding – DP Interaction
1. Coding Supervisor promptly informs DA about any discrepancies in the questionnaire 2. To keep DP updated on coding progress , supervisor promptly give questionnaire arrival and coding status report tom DA 3. When clarification required in coding, Supervisor contacts DA and DA clarifies his/her doubts immediately 4. Coding schedules are agreed upon by both Coding supervisor and DA after mutual consultations 5. Any field errors found they have to inform the DA as soon as possible. 6. Every decision taken by the coding department should be informed to DP department.

Code Frame maintenance

1. Verbatim listings is prepared from 30-50 questionnaire ( no may vary depending on the size of the project) to prepare the preliminary code list and approved by supervisor / DA before starts coding. 2. When they sending the Final code list to the DA , they must mention the question Numbers on each code list. 3. Don’t use any existing code list ( Brand code list ) without the permission of DA. 4. They have to keep one common code list ( especially for brands ) across all the questions. 5. If the verbatim are not translated they should inform the DA as soon as possible. 6. Use common code list wherever possible ( for ex TV Channel , Newspaper Magazines ) 7. Ensure that the codes are not repeated every code should be unique. 8. Thy to send the code list without spelling mistake. 9. Use the Standardized codes for Nothing Dk/Cs Others and also mention these codes on the top of the code list.

Track project coding

1. Ad code frames should be updated promptly adding code list for new ads recalled frequently by the respondents OR ads provided by the researcher. 2. Every month the concerned data analyst is approving code frames. 3. Questionnaire serial number consist of 2 parts i.e Week number and questionnaire serial no. 4. Coding team involved in each project should be familiarized with ads provided. 5. Coder should consult supervisor before adding any new ad code frames.

6. Use standard code list for ECT Message and Story Board ( CR ) message. 7. In ECT Code first 3 digit should be Brand and then next 2 digit should ad code. 8. Category Generic code is always 99999/99900. 9. For every new story board added there should be the corresponding ad code list for ECT part coding.

Quality Guidelines

1. Supervisor has to physically check the first 10 questionnaire of which coding completed to see if the coder have understood coding instructions and strictly followed it or not. 2. Supervisor should keep checking the code frame very hour to ensure the quality of code frames. 3. Before sending each days code questionnaire to data entry suppliers he she had to ensure that coders checklist procedure is done. 4. Supervisor must check randomly the open ended codes whether the coders have right or not. 5. Every coder has to write the code numbers neatly so that every one can read. 6. Don’t leave any question as uncoded ( even if it coming low response ) After coding the questionnaire coder should check whether he/she has coded everything properly.

Questionnaire management

1. Every questionnaire should have a unique number preferably the Serial number format should be Center code + Serial Number 2. After every questionnaire lot received from the field count the questionnaire and record in the appropriate questionnaire maintenance records promptly.

3. The questionnaire status should be maintained properly.

Analysis department – This is the division in which all analysis for the project like
SD/Tests/Correlations/regression has been done according to the requirement of the clients. This department works independently from data collection department. After collecting verifying the data from the samples data collection department dispatch all the filled forms to this department.

Data Collection
This report was prepared after collecting data from the various doctors after having a small discussion on some structured question. Primary data: These data were collected by personal interview with specialist doctors(Pediatrician, Dermatologist, Gynecologist, General Phycian). Fr this purpose questionnaire were prepared in such that all necessary data would be collected.

Secondary data: Secondary data was not required for the study as client wanted the current situation of the market.

Data Analysis & Interpretation
After the data was collected, the real task was started. The analysis of data required a number of closely related operation such as establishment of categories, the application of these categories to raw data through coding, tabulation and then drawing statistical inference. The unwieldy data was condensed into a few manageable groups and table for further analysis. Thus classified the data into some purposeful and usable categories. Coding, editing and tabulation was done simultaneously and then analysis was being done with the help of SPSS Software and MS excel.

=========================================================

ANALYSIS USING SPSS

1.Factors

influences Doctors t keep stock.

Factors influences Doctors to keep stocks
40

30

20

10

Count

0 availability brand

STOCK

 Graphs show that brand plays a very important role and out of 40 doctors, 35 doctors consider Brand as one of the most important thing while keeping stock.

2. Most serious disease.

Most serious disease
20

18

10

9 7 5
Count
0 chicken pox Genital w arts HIV Vulval cancer Cervical cancer

SERIOUS

 As per the above graph Cervical cancer is the most serious disease and out of 40 doctors, 18 doctors says that Cervical cancer is the most dangerous disease.

3. Most serious disease
.

Most serious disease
chicken pox Vulval cancer 17.5% 2.5% Genital w arts 22.5%

HIV 12.5% Cervical cancer 45.0%

 As per the above graph cervical cancer is the most serious disease and in terms of percentage 45% doctors says that cervical cancer is the most dangerous disease.

4. Brand Awareness

Brand awarenes of Cervical cancer vaccines among Doctors
30

20

21

14 10

Count

5 0

G SK

M c er /M SD k

st Pa fi no Sa r eu

DACV

 As per the above graph MSD/Merck is the most popular cervical cancer vaccine among doctors in Bangalore with 21 among sample size of 40. Others are GSK And Sanofi Pasteur with 14 and 5 respectively.

5. Ability of brand to satisfy the customer

 As per the above chart it can be easily depicted that between Gardasil and Cervarix, Gardasil is the most favourable vaccine for the customer. 55% of the doctors accepted that Gardasil vaccine is features t control the Cervical cancer.

6.Association with brands

 As per the above pie chart Gardasil with 72% of the sample is the most associated brand for cervical cancer treatment.

7.Risk of Cervical cancer among women in India

 From the above pie chart the risk of Cervical cancer among women in India is having no risk at all. It is showing that 37% of the sample suggest that It is not very risky. But 25% doctors are saying that It is having high risk among women.

Conclusion:
Cervical cancer is the most common cancer among women in developing countries, accounting for almost 10% of cancer in males and females combined. It is estimated that, in the absence of any control programme, the incident number of cervical cancer in India will rise very rapidly.
The present study was undertaken to examine if the vaccines available in the market is efficient enough or not. How is it satisfactory for the patients and doctors?

From the above study and analysis it has been concluded that:  Cervical cancer is the most risky disease among women in India. Majority of the specialist doctors of Bangalore said that it is very risky in lower socio economic class.  From the analysis it can be said that there is a lack of awareness among people about it.  The Brand of vaccine plays very important role for doctors while keeping stock. According to analysis 35 out of 40 doctors said that the brand name plays a crucial role while keeping the stock. Generally they prefer big brands.
 It has also been seen that 45% says that Cervical cancer is the most dangerous among

women in India. From the study MSD/Merck is the most popular cervical cancer vaccine among doctors in Bangalore with 21 among sample size of 40. Others are GSK And Sanofi Pasteur with 14 and 5 respectively.
 It is analyzed that Gardasil with 72% of the sample is the most associated brand for

cervical cancer treatment and it is the most favorable brand for the doctors and patients with very high effectiveness. In comparison with Gardasil, Cervarix has a low market share and low efficacy. Most of the doctors prescribed their patients to use Gardasil instead of Cervarix.

Recommendation:
From this study it can be recommended that the awareness of this disease is a great concern. Especially in lower socio economic class there is a great risk of this disease. As per the study it can be concluded that company should keep the price factor of their vaccines in mind because lower economic class can’t afford such costly vaccines. It can be also recommended that the distribution system for Gardasil should be strengthened. As from the study it is analyzed that doctors keep both the brand name and availability of vaccines in their mind while keeping stock.

Limitation of Study:
Although I tried my best in preparation of this project, but this study has some limitations:  It was not very easy to fix appointment with the doctors for a research purpose. Many doctors refused to give appointments for the discussion.  Visiting various places for the study consumed lot of time. Sometimes It used to be very embarrassing when after fixing the appointment doctors were refused to give the time.  What the doctors have revealed will be right for each and every situation because their perception can be influenced by many factors like economical situation of patients, availability of medicines etc.  Some of the doctors showed less interest in providing enough information even after fixing the appointment.

Bibliography
Marketing Research: David j. Luck & Ronald S. Rubin www.tnsglobal.in www.google.co.in

Master your semester with Scribd & The New York Times

Special offer for students: Only $4.99/month.

Master your semester with Scribd & The New York Times

Cancel anytime.